🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to message these profiles directly for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Material Elimination

According to the social media company, the platform has removed violative material and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered communities with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, filled with images of slimming results, glowing reviews and detailed instructions for preparing or administering at residence.

Within moments of entering one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, medical conditions or past usage.

Item Details and Pricing

Inside these communities, messages display dark colored packages with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Although the science behind this drug is sound, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has already seen individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose users to potentially serious medical dangers”.